Published in Clin Neurophysiol on August 22, 2006
Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J Neurol Neurosurg Psychiatry (2010) 1.42
Striatal origin of the pathologic beta oscillations in Parkinson's disease. Proc Natl Acad Sci U S A (2011) 1.35
Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings. J Neurosci (2012) 1.23
Neurosystems: brain rhythms and cognitive processing. Eur J Neurosci (2013) 1.13
Resonance in subthalamo-cortical circuits in Parkinson's disease. Brain (2009) 1.10
The highs and lows of beta activity in cortico-basal ganglia loops. Eur J Neurosci (2014) 1.05
Beta reactivity, prospective facilitation of executive processing, and its dependence on dopaminergic therapy in Parkinson's disease. J Neurosci (2012) 1.01
Motor-cortical oscillations in early stages of Parkinson's disease. J Physiol (2012) 0.98
Contribution of subcortical structures to cognition assessed with invasive electrophysiology in humans. Front Neurosci (2008) 0.90
Transient and state modulation of beta power in human subthalamic nucleus during speech production and finger movement. Neuroscience (2011) 0.83
Subthalamic nucleus local field potential activity helps encode motor effort rather than force in parkinsonism. J Neurosci (2015) 0.82
Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease. Neurobiol Dis (2015) 0.81
Dynamical changes in neurological diseases and anesthesia. Curr Opin Neurobiol (2012) 0.81
Cognitive factors modulate activity within the human subthalamic nucleus during voluntary movement in Parkinson's disease. J Neurosci (2013) 0.80
Co-modulation of finely tuned high-gamma band activity across hemispheres in Parkinson's disease. Clin Neurophysiol (2013) 0.77
Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease. Front Hum Neurosci (2016) 0.76
Event-related desynchronization of motor cortical oscillations in patients with multiple system atrophy. Exp Brain Res (2010) 0.76
Time-course of coherence in the human basal ganglia during voluntary movements. Sci Rep (2016) 0.75
Unusual MR findings of the brain stem in arterial hypertension. AJNR Am J Neuroradiol (2000) 3.47
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology (2008) 2.93
Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage (2006) 1.72
Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology (2011) 1.65
Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort. Eur J Neurol (2011) 1.53
Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 1.47
Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene. Brain (1999) 1.46
Stimulation of the subthalamic nucleus in Parkinson's disease: cognitive and affective changes are not linked to the motor outcome. Parkinsonism Relat Disord (2006) 1.45
Cortical involvement in the sensory and motor symptoms of primary restless legs syndrome. Sleep Med (2009) 1.43
The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.43
Paroxysmal kinesigenic choreoathetosis as a presenting symptom of multiple sclerosis. J Neurol (2000) 1.42
Dystonia after striatopallidal and thalamic stroke: clinicoradiological correlations and pathophysiological mechanisms. J Neurol Neurosurg Psychiatry (1998) 1.37
Long-term follow-up of neurosarcoidosis. Neurology (2001) 1.36
Does post-movement beta synchronization reflect an idling motor cortex? Neuroreport (2001) 1.26
Transpedicular screw placement: image-guided versus lateral-view fluoroscopy: in vitro simulation. Spine (Phila Pa 1976) (2001) 1.25
Outer retinal dysfunction in patients treated with vigabatrin. Neurology (1999) 1.24
A specific clinical pattern of camptocormia in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.23
Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med (2001) 1.21
Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature. Rheumatol Int (2007) 1.20
Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases. Brain (2001) 1.17
Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. J Neurol (2001) 1.15
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology (2005) 1.15
Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) (2007) 1.12
Characterization of DCTN1 genetic variability in neurodegeneration. Neurology (2009) 1.11
Sleep disorders in aging and dementia. J Nutr Health Aging (2010) 1.10
Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology (2007) 1.10
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry (2004) 1.09
Statistical tools for clinical gait analysis. Gait Posture (2004) 1.08
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.08
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.05
Study of circadian melatonin secretion pattern at different stages of Parkinson's disease. Clin Neuropharmacol (2003) 1.05
[Interest of the ketogenic diet in a refractory status epilepticus in adults]. Rev Neurol (Paris) (2008) 1.05
Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology (2004) 1.04
[Lithium-induced encephalopathy mimicking Creutzfeldt-Jakob disease]. Rev Neurol (Paris) (2006) 1.04
Neurophysiology of myoclonus. Neurophysiol Clin (2006) 1.04
Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease. Fundam Clin Pharmacol (2010) 1.03
Partly native epitopes are already present on early intermediates in the folding of tryptophan synthase. Proc Natl Acad Sci U S A (1987) 1.03
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J Med Genet (2009) 1.01
Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry (1993) 1.00
Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease. Neurology (2011) 0.99
Somatostatin, a potent analgesic. Lancet (1984) 0.98
Relationship between event-related beta synchronization and afferent inputs: analysis of finger movement and peripheral nerve stimulations. Clin Neurophysiol (2006) 0.97
[Benign intracranial hypertension and Marchiafava-Micheli disease]. Rev Neurol (Paris) (1986) 0.95
Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 0.95
Externally provoked freezing of gait in open runways in advanced Parkinson's disease results from motor and mental collapse. J Neural Transm (Vienna) (2008) 0.95
Association of Lhermitte-Duclos and Cowden disease: report of a new case and review of the literature. J Neurol Neurosurg Psychiatry (1994) 0.95
Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study. Sleep Med (2006) 0.95
Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data. J Neurol Neurosurg Psychiatry (2000) 0.94
[Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase]. Rev Neurol (Paris) (2006) 0.94
No pathogenic mutations in the beta-synuclein gene in Parkinson's disease. Neurosci Lett (1999) 0.94
Afferent-induced facilitation of primary motor cortex excitability in the region controlling hand muscles in humans. Eur J Neurosci (2009) 0.93
Single-trial decoding of auditory novelty responses facilitates the detection of residual consciousness. Neuroimage (2013) 0.93
Cerebral arteriovenous malformations in children: report on 62 cases. Childs Nerv Syst (1994) 0.93
Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J Neurol Neurosurg Psychiatry (1999) 0.92
Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease. J Neurol (1999) 0.92
[Hypothermia and multiple sclerosis. A case with 3 episodes of transient hypothermia]. Rev Neurol (Paris) (1990) 0.92
Evaluation of event-related desynchronization (ERD) during a recognition task: effect of attention. Electroencephalogr Clin Neurophysiol (1993) 0.91